For: | Long XQ, Liu MZ, Liu ZH, Xia LZ, Lu SP, Xu XP, Wu MH. Bile acids and their receptors: Potential therapeutic targets in inflammatory bowel disease. World J Gastroenterol 2023; 29(27): 4252-4270 [PMID: 37545642 DOI: 10.3748/wjg.v29.i27.4252] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v29/i27/4252.htm |
Number | Citing Articles |
1 |
Miljana Nenkov, Yihui Shi, Yunxia Ma, Nikolaus Gaßler, Yuan Chen. Targeting Farnesoid X Receptor in Tumor and the Tumor Microenvironment: Implication for Therapy. International Journal of Molecular Sciences 2023; 25(1): 6 doi: 10.3390/ijms25010006
|
2 |
Samantha H. Bai, Arun Chandnani, Siyan Cao. Bile Acids in Inflammatory Bowel Disease: From Pathophysiology to Treatment. Biomedicines 2024; 12(12): 2910 doi: 10.3390/biomedicines12122910
|
3 |
Danlin Wang, Liang Song, Lei Guan, Yi Lu, Ying Han. Progress in Liver Cancer Associated to Autoimmune Liver Disease. Journal of Contemporary Medical Practice 2025; 7(2): 103 doi: 10.53469/jcmp.2025.07(02).20
|
4 |
Zhining Tang, Yang Yang, Mingrui Yang, Da Jiang, Yao Ge, Xinyu Zhang, Haozhen Liu, Qingyao Fu, Xiyuan Liu, Ying Yang, Zhenlong Wu, Yun Ji. Elucidating the modulatory role of dietary hydroxyproline on the integrity and functional performance of the intestinal barrier in early-weaned piglets: A comprehensive analysis of its interplay with the gut microbiota and metabolites. International Immunopharmacology 2024; 134: 112268 doi: 10.1016/j.intimp.2024.112268
|
5 |
Si Wang, Lei Li, Yuhan Chen, Qian Liu, Shengyu Zhou, Ning Li, Yueying Wu, Jiali Yuan. Houttuynia cordata thunb. alleviates inflammatory bowel disease by modulating intestinal microenvironment: a research review. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1306375
|
6 |
Stacie Summers, Jessica Quimby. Insights into the gut-kidney axis and implications for chronic kidney disease management in cats and dogs. The Veterinary Journal 2024; 306: 106181 doi: 10.1016/j.tvjl.2024.106181
|
7 |
Yueyue Ma, Haoze Yang, Xiaoming Wang, Yuhong Huang, Yuhong Li, Guixiang Pan. Bile acids as signaling molecules in inflammatory bowel disease: Implications for treatment strategies. Journal of Ethnopharmacology 2025; 337: 118968 doi: 10.1016/j.jep.2024.118968
|
8 |
Yao Li, Lulu Wang, Qing Yi, Linsong Luo, Yuxia Xiong. Regulation of bile acids and their receptor FXR in metabolic diseases. Frontiers in Nutrition 2024; 11 doi: 10.3389/fnut.2024.1447878
|
9 |
Lihua Fang, Jie Ning. Recent advances in gut microbiota and thyroid disease: pathogenesis and therapeutics in autoimmune, neoplastic, and nodular conditions. Frontiers in Cellular and Infection Microbiology 2024; 14 doi: 10.3389/fcimb.2024.1465928
|
10 |
Shi-Yan Zhang. Navigating new horizons in inflammatory bowel disease: Integrative approaches and innovations. World Journal of Gastroenterology 2024; 30(41): 4411-4416 doi: 10.3748/wjg.v30.i41.4411
|
11 |
Xiongquan Long, Yuyang Zhang, Mingzhu Liu, Zihao Liu, Lvzhou Xia, Xiaoping Xu, Minghao Wu. Causality of genetically determined blood metabolites on inflammatory bowel disease: a two-sample Mendelian randomization study. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-67376-0
|
12 |
Role of the afferent lymph as an immunological conduit to analyze tissue antigenic and inflammatory load. Cell Reports 2024; 43(6): 114311 doi: 10.1016/j.celrep.2024.114311
|
13 |
Sen Yang, Hanmin Liu, Yang Liu. Advances in intestinal epithelium and gut microbiota interaction. Frontiers in Microbiology 2025; 16 doi: 10.3389/fmicb.2025.1499202
|